Joao Pedro Ferreira Selected Research

Joao Pedro Ferreira Research Topics

13	Heart Failure 11/2023 - 12/2020
2	Body Weight (Weight, Body) 08/2023 - 01/2021
1	Coronary Disease (Coronary Heart Disease) 11/2023
1	Ischemic Stroke 11/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Albuminuria 01/2023
1	Atherosclerosis 01/2023
1	Inflammation (Inflammations) 01/2023
1	Hypotension (Low Blood Pressure) 01/2022
1	Disease Progression 01/2021
1	Atrial Fibrillation 01/2021

9	empagliflozinIBA 08/2023 - 12/2020
3	Sodium-Glucose Transport ProteinsIBA 02/2022 - 01/2021
2	pro-brain natriuretic peptide (1-76)IBA 08/2023 - 01/2023
2	DiureticsIBA 08/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	Troponin T (Troponin T1)IBA 01/2023 - 01/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 01/2023
2	Natriuretic PeptidesIBA 01/2021 - 01/2021
1	RivaroxabanIBA 11/2023
1	InterleukinsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023
1	SodiumIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	SymportersIBA 12/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021
1	Neprilysin (Neutral Endopeptidase)IBA 11/2021
1	TroponinIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021

4	Therapeutics 11/2023 - 10/2021
1	Critical Care (Surgical Intensive Care) 10/2021